Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning

NCT07509632 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancers
Pathological Complete Response
Neoadjuvant Chemoradiotherapy
Machine Learning

Interventions

DIAGNOSTIC_TEST: No interventions

Sponsor

Peking University People's Hospital